Petersen, Ronald C.

Decreased Expression of Sulfatase 2 in the Brains of Alzheimer’s Disease Patients: Implications for Regulation of Neuronal Cell Signaling

Roberts, R. O., Kang, Y. N., Hu, C., Moser, C. D., Wang, S., Moore, M. J., Graham, R. P., Lai, J.-P., Petersen, R. C., & Roberts, L. R. (2017) · Journal of Alzheimer's Disease Reports

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 19

Amyloid-β predominant Alzheimer’s disease neuropathologic change

Kovacs, G. G., Katsumata, Y., Wu, X., Aung, K. Z., Fardo, D. W., Forrest, S. L., Alzheimer's Disease Genetics Consortium, Bowen, J. D., Crane, P. K., Jarvik, G. P., et al. (2025) · Brain

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 19

FedFSA: Hybrid and federated framework for functional status ascertainment across institutions

Fu, S., Jia, H., Vassilaki, M., Keloth, V. K., Dang, Y., Zhou, Y., Garg, M., Petersen, R. C., St Sauver, J., Moon, S., et al. (2024) · Journal of Biomedical Informatics

Machine Learning in HealthcareBiomedical Text Mining and Ontologies

Cited by 17

In vivo cortical diffusion imaging relates to Alzheimer's disease neuropathology

Torso, M., Ridgway, G. R., Valotti, M., Hardingham, I., Chance, S. A., for the National Alzheimer’s Coordinating Center, Brewer, J., Lopez, O., Hyman, B., Grabowski, T., et al. (2023) · Alzheimer's Research & Therapy

Dementia and Cognitive Impairment ResearchAdvanced Neuroimaging Techniques and Applications

Cited by 16

Association between physical activity and longitudinal change in body mass index in middle-aged and older adults

Cleven, L., Syrjanen, J. A., Geda, Y. E., Christenson, L. R., Petersen, R. C., Vassilaki, M., Woll, A., & Krell-Roesch, J. (2023) · BMC Public Health

Physical Activity and HealthObesity, Physical Activity, Diet

Cited by 16

Association of ABI3 and PLCG2 Missense Variants With Disease Risk and Neuropathology in Lewy Body Disease and Progressive Supranuclear Palsy

Strickland, S. L., Morel, H., Prusinski, C., Allen, M., Patel, T. A., Carrasquillo, M. M., Conway, O. J., Lincoln, S. J., Reddy, J. S., Nguyen, T., et al. (2020) · Acta Neuropathologica Communications

Parkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatments

Cited by 15

Circular-SWAT for deep learning based diagnostic classification of Alzheimer's disease: application to metabolome data

Jo, T., Kim, J., Bice, P., Huynh, K., Wang, T., Arnold, M., Meikle, P. J., Giles, C., Kaddurah-Daouk, R., Saykin, A. J., et al. (2023) · eBioMedicine

Dementia and Cognitive Impairment ResearchMetabolomics and Mass Spectrometry Studies

Cited by 15

Quality assessment of functional status documentation in EHRs across different healthcare institutions

Fu, S., Vassilaki, M., Ibrahim, O. A., Petersen, R. C., Pagali, S., St Sauver, J., Moon, S., Wang, L., Fan, J. W., Liu, H., et al. (2022) · Frontiers in Digital Health

Electronic Health Records SystemsNursing Diagnosis and Documentation

Cited by 15

Aducanumab: What about the Patient?

Petersen, R. C. (2021) · Annals of Neurology

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 14

E.U./U.S. CTAD TASK FORCE ON ALZHEIMER\'S TRIAL POPULATIONS

Vellas, B., Sampaio, C., Bateman, R., Boxer, A., Carrillo, M. C., Cummings, J., Dubois, B., Hampel, H., Katz, R., Khachaturian, Z., et al. (2014) · The Journal of Prevention of Alzheimer's Disease

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 5